Related Experiment Video
Updated: Jul 1, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Psychological mediators of bupropion sustained-release treatment for smoking cessation
Danielle E McCarthy1, Thomas M Piasecki, Daniel L Lawrence
1Department of Psychology, Rutgers-The State University of New Jersey, 152 Frelinghuysen Road, Piscataway, NJ 08854, USA. demccart@rci.rutgers.edu
Aim:
The study aimed to test simultaneously our understanding of the effects of bupropion sustained-release (SR) treatment on putative mediators and our understanding of determinants of post-quit abstinence, including withdrawal distress, cigarette craving, positive affect and subjective reactions to cigarettes smoked during a lapse. The specificity of bupropion SR effects was also tested in exploratory analyses.
Design:
Data from a randomized, placebo-controlled clinical trial of bupropion SR were submitted to mediation analyses.
Setting:
Center for Tobacco Research and Intervention, Madison, WI, USA.
Participants:
A total of 403 adult, daily smokers without contraindications to bupropion SR use.
Intervention:
Participants were assigned randomly to receive a 9-week course of bupropion SR or placebo pill and to receive eight brief individual counseling sessions or no counseling.
Measurements:
Ecological momentary assessment ratings of smoking behavior and putative mediators were collected pre- and post-quit.
Findings:
Results of structural equation and hierarchical linear models did not support the hypothesis that bupropion SR treatment improves short-term abstinence by reducing withdrawal distress or affecting the subjective effects of a lapse cigarette, but provided partial support for mediation by cigarette craving reduction and enhanced positive affect. Bupropion SR effects on point-prevalence abstinence at 1 month post-quit were also mediated partially by enhanced motivation to quit and self-efficacy.
Conclusions:
Results provided some support for models of bupropion SR treatment and relapse and suggested that motivational processes may partially account for bupropion SR efficacy.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
The Placebo Effect
Drug Dependence
Oral Drug Delivery Systems: Continuous-Release Systems
CNS Depressants: Alcohol and Nicotine
Anxiolytic Drugs: Benzodiazepines and Buspirone